Association between periodontitis and hyperlipidaemia: A systematic review and meta‐analysis

Jing Xu,Xiaoqi Duan
DOI: https://doi.org/10.1111/1440-1681.13372
2020-07-20
Clinical and Experimental Pharmacology and Physiology
Abstract:<p>To date, it has been reported that periodontitis (PD) may be associated with hyperlipidemia in the clinical practice. However, data on this issue are inconsistent and controversial. The purpose of this meta‐analysis was to identify the association between PD and hyperlipidemia. Here, 21 case‐control and 8 cross‐sectional studies on PD and hyperlipidemia were included in the random‐effects meta‐analysis, involving 2060 patients with PD and 2776 healthy controls (HC). Meta‐analysis showed that serum triglyceride (TG) and total cholesterol (TC) levels in PD group were significantly higher than those in HC group [TG, weighted mean difference (WMD) = 19.4 mg/dl, 95% confidence interval (CI): (13.3‐25.5) mg/dl, P=0.000; TC, WMD=15.4 mg/dl, 95%CI: (10.2‐20.6) mg/dl, P=0.000]. Subgroup analysis stratified by study design validated that PD was associated with higher serum TG and TC levels. In addition, compared with HC group, serum low‐density lipoprotein (LDL) in patients with PD showed a markedly higher level [WMD=11.7 mg/dl, 95%CI: (8.3‐15.0) mg/dl, P=0.000], whereas serum high‐density lipoprotein (HDL) in PD group exhibited a significantly lower level [WMD= ‐4.5 mg/dl, 95%CI: (‐6.4~‐2.7) mg/dl, P=0.000]. Finally, no significant publication bias was observed and sensitivity analysis also confirmed the stability of our meta‐analyses. In conclusion, the accumulated evidence suggests that PD is indeed associated with hyperlipidemia in humans. More interventions for lowering lipids or increasing HDL may benefit the patients with PD, which need be further investigated in prospective clinical trials.</p>
pharmacology & pharmacy,physiology
What problem does this paper attempt to address?